Repossini Alberto, Baudo Massimo, D'Alonzo Michele, Petruccelli Rocco, Rosati Fabrizio
Cardiac Surgery, Spedali Civili di Brescia, Brescia, Italy.
University of Brescia Medical School, Cardiac Surgery Unit, Brescia, Italy.
Multimed Man Cardiothorac Surg. 2020 May 22;2020. doi: 10.1510/mmcts.2020.021.
Minimally invasive direct coronary artery bypass (MIDCAB) for a left internal mammary artery on left anterior descending (LIMA-LAD) graft, is a safe and relatively less traumatic surgical technique. Adoption in some centers has been slow because of perceived technical difficulty, but it should be considered a first-choice therapy for patients with isolated proximal LAD lesions or multi-vessel disease, and as a component of a hybrid revascularization strategy. Results in our institute, where we have been using MIDCAB for more than 20 years, confirm both its short- and long-term efficacy. This video tutorial demonstrates the technical aspects of the procedure.
用于左乳内动脉至左前降支搭桥（LIMA-LAD）的微创直接冠状动脉搭桥术是一种安全且创伤相对较小的外科技术。由于被认为技术难度较大，一些中心采用该技术的速度较慢，但对于孤立的近端左前降支病变或多支血管病变患者，应将其视为首选治疗方法，并作为杂交血运重建策略的一部分。在我们研究所，我们使用微创直接冠状动脉搭桥术已有20多年，结果证实了其短期和长期疗效。本视频教程展示了该手术的技术要点。
